| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 6, 607-620, Copyright © 1992 by Endocrine Society
ARTICLES |
CA Beck, NL Weigel and DP Edwards
Department of Pathology, University of Colorado Health Sciences Center, Denver 80262.
Human progesterone receptors (PR) in T47D breast cancer cells are synthesized as two different sized proteins, PR-A [94 kilodaltons (kDa)] and PR-B (120 kDa). Progestin addition to cells (in vivo) causes a 2-fold increase in total phosphorylation of PR and an increase in the apparent mol wt of both PR-A and PR-B on sodium dodecyl sulfate (SDS)- gels. Time-course experiments showed that increased PR phosphorylation that results from hormone addition is a multistep process and involves a rapid increase into total 32P labeling that takes place before the more slowly occurring phosphorylation(s) responsible for the change in electrophoretic mobility of PR on SDS-gels. As an approach to test whether phosphorylation is involved in regulating PR activity, we have examined the effects of cellular modulators of protein phosphorylation on PR-mediated target gene transcription in vivo using a T47D cloned cell line containing a stably transfected mouse mammary tumor virus- chloramphenicol acetyltransferase construct. Treatment with 8-bromo- cAMP (activator of cAMP-dependent protein kinases) or okadaic acid (protein phosphatase-1 and -2A inhibitor) did not stimulate target gene expression in the absence of progestin. When added together with progestin, either compound augmented PR-mediated target gene transcription by 3- to 4-fold. The cyclic nucleotide-dependent protein kinase inhibitor H8 completely blocked target gene responsiveness to hormone. Neither 8-bromo-cAMP, okadaic acid, nor H8 altered the hormone- or DNA-binding activities of PR, as measured in vitro or affected cellular concentrations of PR. These agents, therefore, appeared to selectively modulate PR transcriptional activity. Moreover, none of these compounds altered expression from a control reporter gene, pSV2CAT, indicating that these agents affect PR-mediated processes directly and are not acting through a general effect on transcription. Effects on PR phosphorylation were assessed by measuring 32P labeling of PR in vivo. None of these treatments had a substantial effect on the extent of total 32P labeling of immune isolated PR or on the phosphorylation(s) responsible for PR up-shifts on SDS-gels. This suggests that these agents modulate PR transcriptional activity either through phosphorylation of another protein intimately involved in PR- mediated transcription or through modification of a key site(s) not measurable as a change in total PR phosphorylation or electrophoretic mobility on SDS gels.
This article has been cited by other articles:
![]() |
A. Gordon, J. C Garrido-Gracia, R. Aguilar, S. Guil-Luna, Y. Millan, J. M. de las Mulas, and J. E Sanchez-Criado Ovarian stimulation with FSH reduces phosphorylation of gonadotrope progesterone receptor and LH secretion in the rat Reproduction, January 1, 2009; 137(1): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. de Cremoux, D. Rosenberg, J. Goussard, C. Bremont-Weil, F. Tissier, C. Tran-Perennou, L. Groussin, X. Bertagna, J. Bertherat, and M.-L. Raffin-Sanson Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease Endocr. Relat. Cancer, June 1, 2008; 15(2): 465 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tan, X. Long, H. Nakshatri, K. P Nephew, and R. M Bigsby Striatin-3{gamma} inhibits estrogen receptor activity by recruiting a protein phosphatase J. Mol. Endocrinol., May 1, 2008; 40(5): 199 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mani, A. M. Reyna, J. Z. Chen, B. Mulac-Jericevic, and O. M. Conneely Differential Response of Progesterone Receptor Isoforms in Hormone-Dependent and -Independent Facilitation of Female Sexual Receptivity Mol. Endocrinol., June 1, 2006; 20(6): 1322 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Proia, B. W. Nannenga, L. A. Donehower, and N. L. Weigel Dual Roles for the Phosphatase PPM1D in Regulating Progesterone Receptor Function J. Biol. Chem., March 17, 2006; 281(11): 7089 - 7101. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Narayanan, A. A. Adigun, D. P. Edwards, and N. L. Weigel Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin A/Cdk2 as a Progesterone Receptor Coactivator Mol. Cell. Biol., January 1, 2005; 25(1): 264 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gonzalez-Flores, J. Shu, I. Camacho-Arroyo, and A. M. Etgen Regulation of Lordosis by Cyclic 3',5'-Guanosine Monophosphate, Progesterone, and Its 5{alpha}-Reduced Metabolites Involves Mitogen-Activated Protein Kinase Endocrinology, December 1, 2004; 145(12): 5560 - 5567. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Molenda, C. P. Kilts, R. L. Allen, and M. J. Tetel Nuclear Receptor Coactivator Function in Reproductive Physiology and Behavior Biol Reprod, November 1, 2003; 69(5): 1449 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Coleman, M. Dutertre, A. El-Gharbawy, B. G. Rowan, N. L. Weigel, and C. L. Smith Mechanistic Differences in the Activation of Estrogen Receptor-alpha (ERalpha )- and ERbeta -dependent Gene Expression by cAMP Signaling Pathway(s) J. Biol. Chem., April 4, 2003; 278(15): 12834 - 12845. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labriola, M. Salatino, C. J. Proietti, A. Pecci, O. A. Coso, A. R. Kornblihtt, E. H. Charreau, and P. V. Elizalde Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells Mol. Cell. Biol., February 1, 2003; 23(3): 1095 - 1111. [Abstract] [Full Text] |
||||
![]() |
B. M. Jacobsen, J. K. Richer, S. A. Schittone, and K. B. Horwitz New Human Breast Cancer Cells to Study Progesterone Receptor Isoform Ratio Effects and Ligand-independent Gene Regulation J. Biol. Chem., July 26, 2002; 277(31): 27793 - 27800. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barletta, L. P. Freedman, and S. Christakos Enhancement of VDR-Mediated Transcription by Phosphorylation: Correlation with Increased Interaction Between the VDR and DRIP205, a Subunit of the VDR-Interacting Protein Coactivator Complex Mol. Endocrinol., February 1, 2002; 16(2): 301 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shen, K. B. Horwitz, and C. A. Lange Transcriptional Hyperactivity of Human Progesterone Receptors Is Coupled to Their Ligand-Dependent Down-Regulation by Mitogen-Activated Protein Kinase-Dependent Phosphorylation of Serine 294 Mol. Cell. Biol., September 15, 2001; 21(18): 6122 - 6131. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Rowan, N. Garrison, N. L. Weigel, and B. W. O'Malley 8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein Mol. Cell. Biol., December 1, 2000; 20(23): 8720 - 8730. [Abstract] [Full Text] |
||||
![]() |
G. R. ATTIA, K. ZEITOUN, D. EDWARDS, A. JOHNS, B. R. CARR, and S. E. BULUN Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2897 - 2902. [Abstract] [Full Text] |
||||
![]() |
C. L. Smith, R. G. Wolford, T. B. ONeill, and G. L. Hager Characterization of Transiently and Constitutively Expressed Progesterone Receptors: Evidence for Two Functional States Mol. Endocrinol., July 1, 2000; 14(7): 956 - 971. [Abstract] [Full Text] |
||||
![]() |
B. G. Rowan, N. L. Weigel, and B. W. O'Malley Phosphorylation of Steroid Receptor Coactivator-1. IDENTIFICATION OF THE PHOSPHORYLATION SITES AND PHOSPHORYLATION THROUGH THE MITOGEN-ACTIVATED PROTEIN KINASE PATHWAY J. Biol. Chem., February 11, 2000; 275(6): 4475 - 4483. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Greenland, I. Jantke, S. Jenatschke, K. E. Bracken, C. Vinson, and B. Gellersen The Human NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Gene Promoter Is Controlled by Ets and Activating Protein-1 Transcription Factors and Progesterone Endocrinology, February 1, 2000; 141(2): 581 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Clemm, L. Sherman, V. Boonyaratanakornkit, W. T. Schrader, N. L. Weigel, and D. P. Edwards Differential Hormone-Dependent Phosphorylation of Progesterone Receptor A and B Forms Revealed by a Phosphoserine Site-Specific Monoclonal Antibody Mol. Endocrinol., January 1, 2000; 14(1): 52 - 65. [Abstract] [Full Text] |
||||
![]() |
J. J. Brosens, N. Hayashi, and J. O. White Progesterone Receptor Regulates Decidual Prolactin Expression in Differentiating Human Endometrial Stromal Cells Endocrinology, October 1, 1999; 140(10): 4809 - 4820. [Abstract] [Full Text] |
||||
![]() |
A.-M. Moilanen, U. Karvonen, H. Poukka, O. A. Jänne, and J. J. Palvimo Activation of Androgen Receptor Function by a Novel Nuclear Protein Kinase Mol. Biol. Cell, September 1, 1998; 9(9): 2527 - 2543. [Abstract] [Full Text] |
||||
![]() |
B. L. Wagner, J. D. Norris, T. A. Knotts, N. L. Weigel, and D. P. McDonnell The Nuclear Corepressors NCoR and SMRT Are Key Regulators of Both Ligand- and 8-Bromo-Cyclic AMP-Dependent Transcriptional Activity of the Human Progesterone Receptor Mol. Cell. Biol., March 1, 1998; 18(3): 1369 - 1378. [Abstract] [Full Text] |
||||
![]() |
A. Revelli, M. Massobrio, and J. Tesarik Nongenomic Actions of Steroid Hormones in Reproductive Tissues Endocr. Rev., February 1, 1998; 19(1): 3 - 17. [Abstract] [Full Text] |
||||
![]() |
C. L. Bethea and A. A. Widmann Differential Expression of Progestin Receptor Isoforms in the Hypothalamus, Pituitary, and Endometrium of Rhesus Macaques Endocrinology, February 1, 1998; 139(2): 677 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, C. A. Beck, A. Poletti, J. P. Clement IV, P. Prendergast, T.-T. Yip, T. W. Hutchens, D. P. Edwards, and N. L. Weigel Phosphorylation of Human Progesterone Receptor by Cyclin-Dependent Kinase 2 on Three Sites That Are Authentic Basal Phosphorylation Sites In Vivo Mol. Endocrinol., June 1, 1997; 11(6): 823 - 832. [Abstract] [Full Text] |
||||
![]() |
W. Bai, B. G. Rowan, V. E. Allgood, B. W. O'Malley, and N. L. Weigel Differential Phosphorylation of Chicken Progesterone Receptor in Hormone-dependent and Ligand-independent Activation J. Biol. Chem., April 18, 1997; 272(16): 10457 - 10463. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Nazareth and N. L. Weigel Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway J. Biol. Chem., August 16, 1996; 271(33): 19900 - 19907. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Beck, Y. Zhang, M. Altmann, N. L. Weigel, and D. P. Edwards Stoichiometry and Site-specific Phosphorylation of Human Progesterone Receptor in Native Target Cells and in the Baculovirus Expression System J. Biol. Chem., August 9, 1996; 271(32): 19546 - 19555. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Takimoto, A. R. Hovland, D. M. Tasset, M. Y. Melville, L. Tung, and K. B. Horwitz Role of Phosphorylation on DNA Binding and Transcriptional Functions of Human Progesterone Receptors J. Biol. Chem., June 7, 1996; 271(23): 13308 - 13316. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bai and N. L. Weigel Phosphorylation of Ser211 in the Chicken Progesterone Receptor Modulates its Transcriptional Activity J. Biol. Chem., May 31, 1996; 271(22): 12801 - 12806. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gu, A. A. Rojo, M. C. Zee, J. Yu, and R. B. Simerly Hormonal Regulation of CREB Phosphorylation in the Anteroventral Periventricular Nucleus J. Neurosci., May 1, 1996; 16(9): 3035 - 3044. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Beck, Y. Zhang, N. L. Weigel, and D. P. Edwards Two Types of Anti-progestins Have Distinct Effects on Site-specific Phosphorylation of Human Progesterone Receptor J. Biol. Chem., January 12, 1996; 271(2): 1209 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hurd, N. Khattree, P. Alban, K. Nag, S. C. Jhanwar, S. Dinda, and V. K. Moudgil Hormonal Regulation of the p53 Tumor Suppressor Protein in T47D Human Breast Carcinoma Cell Line J. Biol. Chem., December 1, 1995; 270(48): 28507 - 28510. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lefebvre, M.-P. Gaub, A. Tahayato, Céc. Rochette-Egly, and P. Formstecher Protein Phosphatases 1 and 2A Regulate the Transcriptional and DNA Binding Activities of Retinoic Acid Receptors J. Biol. Chem., May 5, 1995; 270(18): 10806 - 10816. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Knotts, R. S. Orkiszewski, R. G. Cook, D. P. Edwards, and N. L. Weigel Identification of a Phosphorylation Site in the Hinge Region of the Human Progesterone Receptor and Additional Amino-terminal Phosphorylation Sites J. Biol. Chem., March 9, 2001; 276(11): 8475 - 8483. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |